Labshake search
Citations for Invivogen :
1 - 50 of 403 citations for 8H Pyrrolo 2 3 g benzothiazole 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2019Quote: ... 2’,3’-cGAMP (Invivogen) at 10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP) (Invivogen cat. no. tlrl-nacga23), and human IFN-β (PeproTech ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA) (Invivogen cat. no. tlrl-nacda2r), 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP ...
-
bioRxiv - Immunology 2023Quote: ... 2′-3′cGAMP was from InvivoGen, human recombinant sTREM2 was from Sino Biological ...
-
bioRxiv - Cell Biology 2022Quote: ... the cationic lipid-based transfection reagent LyoVec and cyclic [G(2’,5’)pA(3’,5’)p] (2’3’-cGAMP) were obtained from Invivogen (San Diego, USA) and Lipofectamine2000 was obtained from ThermoFisher Scientific (Dreieich ...
-
bioRxiv - Immunology 2021Quote: ... or 2’-3’cGAMP (4µg/ml, Invivogen) for the specified times ...
-
bioRxiv - Immunology 2024Quote: ... or 2µg/mL 2’,3’-cGAMP (InvivoGen), or 2µg/mL poly(I:C ...
-
bioRxiv - Cell Biology 2023Quote: ... + 2% Ultroser G (Cytogen, Germany) and 0.2% primocin (InvivoGen, USA). The alveolar cells were grown and differentiated under ALI conditions in AEpiCM-Alveolar Epithelial Cell Medium (ScienCell ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.2 µg/g was used for all experiments (InvivoGen, tlrl-nacairs-2). Anti-PD1 (InvivoGen ...
-
bioRxiv - Systems Biology 2021Quote: ... 2’,3’-cyclic GMP-AMP (cGAMP) (Invivogen #tlrl-nacga23-5) at a concentration of 1 mg/mL (final concentration in the well 100 ug/mL ...
-
bioRxiv - Immunology 2021Quote: ... 2’-3’-cGAMP and c-di-UMP were purchased from Invivogen. EFV was purchased from Bristol-Myers Squibb.
-
Nucleic acid sensing by STING induces an interferon-like antiviral response in a marine invertebratebioRxiv - Immunology 2022Quote: ... Elution was performed with free 2′3′-cGAMP (100 μM; InvivoGen), 3′3′-cGAMP (100 μM ...
-
bioRxiv - Cell Biology 2023Quote: ... 4 µM digitonin) with or without 7 µM 2’,3’-cGAMP (Invivogen). Cells were further washed in PBS and incubated in culture medium until collection ...
-
bioRxiv - Genetics 2019Quote: ... For stable sgRNA and shRNA expression 3 days puromycin (2 μg/ml, Invivogen) selection was applied.
-
Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistancebioRxiv - Cancer Biology 2024Quote: ... Infected cells were selected using puromycin for 3 days (2 µg/ml, InvivoGen) or hygromycin B for 7 days (500 µg/ml ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated with 12.5 or 25 μg/mL 2’-3’cGAMP (Invivogen tlrl-nacga23) for 2 hr as indicated ...
-
bioRxiv - Immunology 2022Quote: ... 3′3′-cyclic-di-AMP (3′3′ CDA) (Invivogen, cat. no. tlrl-nacda), 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA ...
-
bioRxiv - Immunology 2021Quote: ... Labeled cells (0.5x106 cells/mL) were cultured for 2-3 days with 5 μg/mL R848 (InvivoGen), 50 U/mL IL-2 (Peprotech) ...
-
bioRxiv - Microbiology 2024Quote: ... providing an additional metric for assessing cell health post-drug treatment for both 2’-3’cGAMP (Invivogen) and Sulfasalazine (Cayman Chemical).
-
Nucleic acid sensing by STING induces an interferon-like antiviral response in a marine invertebratebioRxiv - Immunology 2022Quote: ... 3′3′-cGAMP (100 μM; InvivoGen), c-di-AMP (100 µM ...
-
bioRxiv - Neuroscience 2021Quote: ... with half media changes every 2-3 days with Neurobasal (ThermoFisher #21103049 supplemented with Primocin (InvivoGen #ant-pm-1), B-27 (ThermoFisher #17504044 ...
-
bioRxiv - Microbiology 2021Quote: ... were immunized with 3 ugs of purified RBD of SARS-CoV-2 mixed with 10 ugs of poly I:C (Invivogen) twice with 3 weeks interval (17 ...
-
bioRxiv - Immunology 2023Quote: ... the cells were pre-incubated with the respective antagonist as suggested by the manufacturer’s protocol (STING: H-151 for 1-2 hours and cGAS: RU.521 for 3 hours, both InvivoGen, USA) in cell growth medium ...
-
bioRxiv - Immunology 2020Quote: ... clarified by centrifugation and subsequently incubated with Peptide M(Invivogen)/Protein G-coupled sepharose beads (Invivogen, catalog# gel-pdm-5 ...
-
bioRxiv - Microbiology 2024Quote: ... and BS (2.5 .g/ml, InvivoGen) were added ...
-
bioRxiv - Cell Biology 2022Quote: ... 3- methyladenine (Invivogen), bafilomycin A1 (Invivogen) ...
-
bioRxiv - Immunology 2022Quote: ... for 3 hr followed by (flagellin isolated from P. aeruginosa, 2 or 5 µg/mL) for 3 hr using FLA-PA Ultrapure (InvivoGen, tlrl-pafla) according to the manufacturer’s protocol ...
-
bioRxiv - Genetics 2022Quote: ... and 2.5 µ g/ml Plasmocin (InvivoGen).
-
bioRxiv - Bioengineering 2023Quote: ... 4 or 8 µg/ml) or ss-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (InvivoGen, Catalog Code. lyec-12, InvivoGen) following the manufacturer’ ss instructions ...
-
bioRxiv - Immunology 2022Quote: ... immunogen suspensions were gently mixed 1:1 vol/vol with AddaVax adjuvant for immunizations 1 and 2 and O/W for immunization 3 (Invivogen, San Diego, CA) to reach a final concentration of 0.250 mg/mL antigen ...
-
bioRxiv - Immunology 2022Quote: ... 2 ug/mL Pam3CSK4 (TLR1/2 agonist, Invivogen), and 1 ug/mL FSL-1 (TLR2/6 agonist ...
-
bioRxiv - Microbiology 2021Quote: ... and puromycin (3 ug/mL) (InvivoGen). All cell lines were grown at 37°C in 5% CO2.
-
bioRxiv - Immunology 2022Quote: ... and puromycin (3 μg/mL) (InvivoGen). IFNAR KO A549 cells were generated by CRISPR-Cas9 ribonucleoprotein (RNP ...
-
bioRxiv - Biochemistry 2021Quote: ... 3 µg/ml Blasticidin S (InvivoGen) and 0.5 µg/ml Puromycin (Gibco ...
-
bioRxiv - Cell Biology 2023Quote: ... and 3 μg/mL puromycin (Invivogen). For immunoblotting experiments ...
-
bioRxiv - Bioengineering 2021Quote: ... and 2 µl/ml primicin (Ant-pm-2, InvivoGen) at 37°C for 19 hours.
-
bioRxiv - Bioengineering 2022Quote: ... and 2 μl/ml primocin (Ant-pm-2, InvivoGen) at 37°C for 19 hours ...
-
bioRxiv - Immunology 2022Quote: ... 3 μg/mL puromycin (Invivogen, CA, USA) and 0.1 mg/mL Normocin (Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... a toll-like receptor 3 agonist (InvivoGen). Peptide doses of 50 ...
-
bioRxiv - Cell Biology 2022Quote: ... Selection with Puromicin (3 μg/ml; InvivoGen) started 72 h post infection ...
-
bioRxiv - Immunology 2023Quote: ... 3 hours before infection Pam3CSK4 (Invivogen, tlrl-pms) was spiked into the wells at a final of 100 ng/mL ...
-
bioRxiv - Molecular Biology 2021Quote: ... or on solid YPD-agar (1% yeast extract, 2% peptone, 2% D-glucose, 2% agar) and selected with 100 µg/ml Zeocin® (InvivoGen). For small scale expression screening ...
-
bioRxiv - Developmental Biology 2019Quote: ... followed by selection using 2 μg/ml of puromycin (Invivogen, 58-58-2) for 2–3 days starting from 2 days after infection ...
-
bioRxiv - Immunology 2020Quote: ... for 3 days with 0.5 μg/mL LPS (Invivogen) and 0.5 μg/mL anti-IgM F(ab’)2 (Jackson ImmunoResearch) ...
-
bioRxiv - Bioengineering 2022Quote: ... (3) LPS and 150 μg/ml Polymyxin B (Invivogen) for 45 and 90 min ...
-
bioRxiv - Immunology 2022Quote: ... which were selected by blasticidin (3 μg/ml, InvivoGen) for 4 days prior to the experiments.
-
bioRxiv - Immunology 2022Quote: ... or Alum (Alhydrogel 2%, InvivoGen) at 50% v/v at final volume of 30µl per dose ...
-
bioRxiv - Immunology 2020Quote: ... R848 (2 μg/mL, InvivoGen), CHIKV-LR at a multiplicity of infection (MOI ...
-
bioRxiv - Cancer Biology 2022Quote: ... supplemented with 2% Primocin (Invivogen) at 4°C and transported on ice to be processed within 24 hours for organoid culture ...
-
bioRxiv - Molecular Biology 2023Quote: ... THP-1 Null 2 (InvivoGen), THP-1 Null 2 NLRP3 KO (InvivoGen ...